Gilead offers Gilead Oncology Support for patients prescribed Trodelvy. Gilead Oncology Support is a patient support program that helps patients and healthcare providers understand the coverage and financial support options to access Trodelvy.
For more information, go to www.gileadoncologysupport.com or call 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.
Oncology-related products: Trodelvy® (sacituzumab govitecan-hziy) for injection
Gilead Oncology Support Patient Assistance Program
Patients who are uninsured may be eligible to obtain access to Trodelvy at no cost through the Gilead Patient Assistance Program. To qualify for assistance, patients must meet certain eligibility criteria.
To determine patient eligibility, submit an enrollment online at www.gileadoncologysupport.com or call 1.833.851.4344. A program specialist will contact the healthcare provider's office with determination of the patient’s eligibility.
For more information regarding the program, contact 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.
Gilead Oncology Support
Gilead Oncology Support is a patient access and reimbursement support program. Reimbursement support offerings include:
For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.
Gilead Oncology Support information on additional assistance options
Gilead Oncology Support program specialists can provide patients who are unable to afford their medication (including those with Medicare, Medicaid, or other government-sponsored insurance) or need other resources with information about independent third-party organizations that may be able to help. Healthcare professionals or patients can call 1.844.876.3358, option 4, for more information.
Gilead Oncology Support Co-pay Program
Gilead Oncology Support provides savings on out-of-pocket expenses for patients prescribed Trodelvy for commercially or privately insured patients. Patients may pay as little as $0 out of pocket for Trodelvy, which includes co-pay and coinsurance, up to $25,000 annually.
Patients are responsible for cost share of other treatments and office visits. This program does not support any claims covered, paid, or reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs.
To enroll, visit www.gileadoncologysupport.com or call 1.833.851.4344.
For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.
Oncology-related products: Trodelvy™ (sacituzumab govitecan-hziy) for injection